Recommended CRITICS

Home | Marcia Angell, Harvard Professor, Editor of NEJM | Jason Fung, Nephrologist | Ben Goldacre, Prof. and found of AllTrials | Prof. Peter Gotzsche--uncompromizing | David Healy psychiatrist

Ben Goldacre, Prof. and found of AllTrials

Benjamin Michael "Ben" GoldacreMRCPsych (born 1974) is a British physician, academic and science writer. As of 2014 he is a Wellcome research fellow in epidemiology at the London School of Hygiene and Tropical Medicine.[2]  As of March 2015, he is a Senior Clinical Research Fellow at the Centre for Evidence-Based Medicine, based at Department of Primary Care Health Sciences at the University of Oxford.[2]  He is a founder of the AllTrials campaign to require open science practices in clinical trials.  Given the UK system tracks patient and the drugs they take, opening that information would permit a very inexpensive way to track side effects and effectiveness of real world treatments.  

Goldacre is known in particular for his "Bad Science" column in The Guardian, and is the author of two books, The best seller Bad Science (2008), is a critique of irrationality and certain forms of alternative medicine.  His Bad Pharma (2012), an examination of the pharmaceutical industry, its publishing and marketing practices, and its relationship with the medical profession. Goldacre frequently delivers free talks about bad science.  His often starts with missing clinical trials in explain how the information is distorted (youtube). 

Goldacre is the son of Michael Goldacre, a professor of public health at the University of Oxford, and the pop singer Susan Traynor, aka Noosha Fox, both of whom are Australian.  Goldacre passed the MRCPsych Part II examinations in December 2005 and became a member of the Royal College of Psychiatrists. He was a research fellow at the Institute of Psychiatry in London in 2008,[12][dead link] and a Guardian research fellow at Nuffield College, Oxford, in 2009.[13] As of 2012 he was Wellcome research fellow in epidemiology at the London School of Hygiene and Tropical Medicine.

AllTrials (sometimes called All Trials or is a project advocating that clinical research adopt the principles of open research. The project summarizes itself as "All trials registered, all results reported": that is, all clinical trials should be listed in a clinical trials registry, and their results should always be shared as open data.  At the center of the organisation is a petition signed by over 85,000 individuals and 599 organisations (as of August 2015).  The movement is attempting to persuade the European Medical Union to legislate a requirement for the raw data from clinical trials to become available to at least qualified researchers.  The current system of pharma ownership of trial data entails that peer review in any meaningful sense is not possible.  As a result all industry funded trials are grossly biased.  One study using the raw data found a 32 percent positive bias when comparing the raw data to the published journal articles.  This rare glimpse was the result of a group of professors obtain through the US Freedom of Information Act the raw data submitted to the FDA of phase iii clinical trials.  Some of these trials resulted in 74 journal articles.  With such freedom, the system of information which doctors rely upon prevents properly informed choices. 

Bad Pharma: How Drug Companies Mislead Doctors and Harm Patientsis a book by British physician and academic Ben Goldacre about thepharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products.[1]The book was published in September 2012 in the UK by the Fourth Estateimprint of HarperCollins, and in February 2013 in the United States byFaber and Faber.

Goldacre argues in the book that "the whole edifice of medicine is broken" because the evidence on which it is based is systematically distorted by the pharmaceutical industry.[2] He writes that the industry finances most of theclinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and evenghostwritten by pharmaceutical companies or their contractors, without disclosure.[3] Goldacre calls the situation a "murderous disaster," and makes suggestions for action by patients' groups, physicians, academics and the industry itself.[4]


From Ben’s book Bad Pharma:  Drugs are tested by the people who manufacture them, in poorly designed trials, on hopelessly small numbers of weird, unrepresentative patients, and analysed using techniques which are flawed by design, in such a way that they exaggerate the benefits of treatments. Unsurprisingly, these trials tend to produce results that favour the manufacturer. When trials throw up results that companies don't like, they are perfectly entitled to hide them from doctors and patients, so we only ever see a distorted picture of any drug's true effects. Regulators see most of the trial data, but only from early on in a drug's life, and even then they don't give this data to doctors or patients, or even to other parts of government. This distorted evidence is then communicated and applied in a distorted fashion. In their forty years of practice after leaving medical school, doctors hear about what works through ad hoc oral traditions, from sales reps, colleagues or journals. But those colleagues can be in the pay of drug companies – often undisclosed – and the journals are too. And so are the patient groups. And finally, academic papers, which everyone thinks of as objective, are often covertly planned and written by people who work directly for the companies, without disclosure.

Three Quotes:  “A perverse system produces perverse results.”  “We have gone from evidence based medicine to opinion based medicine with pharma supplying the opinion makers.”  “The devil is in the details.”